SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Aspira Women's Health Inc. (AWHL) (CIK 0000926617) (AWHL) — Feb 19, 2015

Aspira Women's Health Inc. (AWHL) (CIK 0000926617)
Date: Feb. 19, 2015 · CIK: 0000926617 · Accession: 0000000000-15-010473

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
February 11, 2015
Author
/s/ Jeffr ey P. Riedler
Form
UPLOAD
Company
Aspira Women's Health Inc. (AWHL) (CIK 0000926617)

Letter

February 19 , 2015 Via E -mail Eric Schoen Vice President, Finan ce and Chief Accounting Officer Vermillion, Inc. 12117 Bee Caves Road Building Three, Suite 100 Austin, TX 78738

Re: Vermillion, Inc. Registration Statement on Form S -3 Filed February 11, 2015 File No. 333 -202032

Dear Mr. Schoen :

We have limited our review of your registra tion statement to the issue we have addressed in the comment below.

1. Please update your financial statements to comply with Rule 8 -08 of Regulation S -X and provide corresponding updated disclosures throughout your filing.

We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Act of 193 3 and all applicable Securities Act rules require. Since the company and its management are in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made.

Notwithstanding our comment , in the event you request acceleration of the effective date of the pending registration statement please provide a written statement from the company acknowledging that:

 should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 the action of the Commission or the staff, acting pu rsuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

Eric Schoen Vermillion , Inc. February 19 , 2015 Page 2

 the company may not assert staff comments and the declaration o f effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Please refer to Rules 460 and 461 regarding requests for acceleration . We will consider a written request for acceleration of the effective date of the registration statement as confirmation of the fact that those requesting acceleration are aware of their respective responsibilities under the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed public offering of the securities specified in the above registration statement. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement.

You may contact Pres ton Brewer at (202) 551 -3969 or me at (202) 551 -3715 with any questions.

Sincerely,
/s/ Jeffr ey P. Riedler

Show Raw Text
February 19 , 2015

Via E -mail
Eric Schoen
Vice President, Finan ce and Chief Accounting Officer
Vermillion, Inc.
12117 Bee Caves Road
Building Three, Suite 100
Austin, TX 78738

Re: Vermillion, Inc.
  Registration Statement on Form S -3
Filed February 11, 2015
  File No. 333 -202032

Dear Mr. Schoen :

We have limited our review of your registra tion statement to the issue we have addressed
in the comment below.

1. Please  update your financial statements to comply with Rule 8 -08 of Regulation S -X and
provide corresponding updated disclosures throughout your filing.

We urge all persons who are responsible for the accuracy and adequacy of the disclosure
in the filing to be  certain that the filing includes the information the Securities Act of 193 3 and
all applicable Securities  Act rules require.   Since the company and its management are in
possession of all facts relating to a company’s disclosure, they are responsible for the accuracy
and adequacy of the disclosures they have made.

Notwithstanding our comment , in the event you request acceleration of the effective date
of the pending registration statement please provide a written statement from the company
acknowledging  that:

 should the Commission or the staff, acting pursuant to delegated authority, declare the
filing effective, it does not foreclose the Commission from taking any action with respect
to the filing;

 the action of the Commission or the staff, acting pu rsuant to delegated authority, in
declaring the filing effective, does not relieve the company from its full responsibility for
the adequacy and accuracy of the disclosure in the filing; and

Eric Schoen
Vermillion , Inc.
February 19 , 2015
Page 2

  the company may not assert staff comments and the declaration o f effectiveness as a
defense in any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.

Please refer to Rules 460 and 461 regarding requests for  acceleration .  We will consider a
written request for  acceleration of the effective date of the registration statement as confirmation
of the fact that those requesting acceleration are aware of their respective responsibilities under
the Securities Act of 1933 and the Securities Exchange Act of 1934 as they  relate to the proposed
public offering of the securities specified in the above registration statement.  Please allow
adequate time  for us to review any amendment prior to the requested effective date of the
registration statement.

You may contact Pres ton Brewer at (202) 551 -3969  or me at (202) 551 -3715 with any
questions.

Sincerely,

 /s/ Jeffr ey P. Riedler

 Jeffrey P. Riedler
 Assistant Director

cc: Via E -Mail
 Beth Flaming , Esq.
 Sidley Austin  LLP